PRPO

SEC source: 0001104659-25-052034 · tm2515963-1_4aseq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Roth IRA for the benefit of Richard A Sandberg

Disclosed balance after: 25,889

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.20 to $8.25, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F1 · ownership.nature: In open market transactions, Mr. Sandberg acquired 4,965 shares through a Roth IRA formed for his benefit, thereby effectively increasing the holdings in which he has a beneficial interest.

SEC source: 0001104659-25-036084 · tm2512512-2_4seq1.xml · nonDerivative · entry 1

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,303

F1 · shares: 2,232 shares of common stock were granted upon the close of business on April 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q1-25.

SEC source: 0001104659-25-036087 · tm2512512-4_4seq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,175

F1 · shares: 2,946 shares of common stock were granted upon the close of business on April 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q1-25.

SEC source: 0001104659-25-036085 · tm2512512-3_4seq1.xml · nonDerivative · entry 1

ANDREWS RONALD ASBURY · CIK 0001299153 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,552

F1 · shares: 1,785 shares of common stock were granted upon the close of business on April 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q1-25.

SEC source: 0001104659-25-036082 · tm2512512-1_4seq1.xml · nonDerivative · entry 1

Cohen David Seth · CIK 0001711622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,054

F1 · shares: 2,343 shares of common stock were granted upon the close of business on April 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q1-25.

SEC source: 0001104659-25-032261 · tm2511509-1_4seq1.xml · nonDerivative · entry 1

Sabet Ahmed Zaki · CIK 0001795929 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 939

SEC source: 0001104659-25-004161 · tm253548-4_4seq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,229

F1 · shares: 2,704 shares of common stock were granted upon the close of business on January 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q4-24.

SEC source: 0001104659-25-004158 · tm253548d3_4seq1.xml · nonDerivative · entry 1

Cossman Jeffrey · CIK 0001710127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,033

F1 · shares: 1,721 shares of common stock were granted upon the close of business on January 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q4-24.

SEC source: 0001104659-25-004156 · tm253548-1_4seq1.xml · nonDerivative · entry 1

ANDREWS RONALD ASBURY · CIK 0001299153 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,767

F1 · shares: 1,639 shares of common stock were granted upon the close of business on January 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q4-24.

SEC source: 0001104659-25-004157 · tm253548-2_4seq1.xml · nonDerivative · entry 1

Cohen David Seth · CIK 0001711622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,711

F1 · shares: 2,151 shares of common stock were granted upon the close of business on January 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q4-24.

SEC source: 0001104659-25-069053 · tm2521234-1_4seq1.xml · nonDerivative · entry 1

Cossman Jeffrey · CIK 0001710127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,033

F1 · shares: 1,721 shares of common stock were granted upon the close of business on January 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q4-24.

SEC source: 0001104659-25-004170 · tm253548-9_4seq1.xml · derivative · entry 1

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance.

SEC source: 0001104659-25-004174 · tm253548-12_4seq1.xml · derivative · entry 1

Gage Matthew · CIK 0001920432 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest and become exercisable on the date that the 10-day volume-weighted average price ("VWAP") of the Company's common stock exceeds $30.30 per share.

SEC source: 0001104659-25-004172 · tm253548-11_4seq1.xml · derivative · entry 1

Valauri Christina Rizopoulos · CIK 0002005448 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance.

SEC source: 0001104659-25-004171 · tm253548-10_4seq1.xml · derivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance.

SEC source: 0001104659-25-004169 · tm253548-8_4seq1.xml · derivative · entry 1

DANIELI ILAN · CIK 0001433130 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest and become exercisable on the date that the 10-day volume-weighted average price ("VWAP") of the Company's common stock exceeds $30.30 per share.

SEC source: 0001104659-25-004167 · tm253548-7_4seq1.xml · derivative · entry 1

Cossman Jeffrey · CIK 0001710127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance.

SEC source: 0001104659-25-004166 · tm253548-6_4seq1.xml · derivative · entry 1

Cohen David Seth · CIK 0001711622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance.

SEC source: 0001104659-25-004164 · tm253548-5_4seq1.xml · derivative · entry 1

ANDREWS RONALD ASBURY · CIK 0001299153 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2035-01-14

F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer.

F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance.

SEC source: 0001104659-24-128463 · tm2431089-1_4seq1.xml · nonDerivative · entry 2

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Roth IRA for the benefit of Richard A Sandberg

Disclosed balance after: 19,525

F1 · balance_after: In open market transactions, Mr. Sandberg decreased his personal holdings by 12,000 shares and instead acquired 15,000 shares through a Roth IRA formed many years ago for his benefit, thereby effectively increasing the holdings in which he has a beneficial interest.

SEC source: 0001104659-24-128463 · tm2431089-1_4seq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,525

F1 · balance_after: In open market transactions, Mr. Sandberg decreased his personal holdings by 12,000 shares and instead acquired 15,000 shares through a Roth IRA formed many years ago for his benefit, thereby effectively increasing the holdings in which he has a beneficial interest.

SEC source: 0001104659-24-131400 · tm2431925-2_4aseq1.xml · nonDerivative · entry 2

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Roth IRA for the benefit of Richard A Sandberg

Disclosed balance after: 19,525

F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.90 to $6.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

F2 · balance_after: In open market transactions, Mr. Sandberg decreased his personal holdings by 12,000 shares and simultaneously acquired 15,000 shares through a Roth IRA formed many years ago for his benefit, thereby effectively increasing the holdings in which he has a beneficial interest.

SEC source: 0001104659-24-131400 · tm2431925-2_4aseq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,525

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.75 to $6.1804, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

F2 · balance_after: In open market transactions, Mr. Sandberg decreased his personal holdings by 12,000 shares and simultaneously acquired 15,000 shares through a Roth IRA formed many years ago for his benefit, thereby effectively increasing the holdings in which he has a beneficial interest.

SEC source: 0001104659-24-117020 · tm2428273-1_4seq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,525

SEC source: 0001104659-24-131398 · tm2431925-1_4aseq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,525

SEC source: 0001104659-24-109556 · tm2426435-5_4seq1.xml · nonDerivative · entry 1

Valauri Christina Rizopoulos · CIK 0002005448 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,021

F1 · price: 1,472 shares of common stock were granted upon the close of business on October 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-24.

SEC source: 0001104659-24-109554 · tm2426435-4_4seq1.xml · nonDerivative · entry 1

SANDBERG RICHARD A · CIK 0001245055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,525

F1 · price: 2,492 shares of common stock were granted upon the close of business on October 15, 2024, as a consideration in lieu of cash payment of deferred compensation for service as a member of the Board of Directors for Q3-24.

SEC source: 0001104659-24-109552 · tm2426435-3_4seq1.xml · nonDerivative · entry 1

Cossman Jeffrey · CIK 0001710127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,312

F1 · price: 1,586 shares of common stock were granted upon the close of business on October 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-24.

SEC source: 0001104659-24-109551 · tm2426435-2_4seq1.xml · nonDerivative · entry 1

Cohen David Seth · CIK 0001711622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,560

F1 · price: 1,982 shares of common stock were granted upon the close of business on October 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-24.

SEC source: 0001104659-24-109550 · tm2426435d1_4seq1.xml · nonDerivative · entry 1

ANDREWS RONALD ASBURY · CIK 0001299153 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,128

F1 · price: 1,510s hares of common stock were granted upon the close of business on October 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-24.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 20

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires 2032-01-11

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 19

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2032-01-11

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 18

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2031-03-08

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 17

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,250 shares

Expires 2031-03-08

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 16

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Common Stock · 1,250 shares

Expires 2031-01-04

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 15

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,250 shares

Expires 2031-01-04

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 14

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200

Underlying: Common Stock · 200 shares

Expires 2030-07-02

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 13

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200 shares

Expires 2030-07-02

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 12

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375

Underlying: Common Stock · 375 shares

Expires 2030-01-16

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 11

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 375 shares

Expires 2030-01-16

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 10

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70

Underlying: Common Stock · 70 shares

Expires 2029-04-17

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 9

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 70 shares

Expires 2029-04-17

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 8

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28

Underlying: Common Stock · 28 shares

Expires 2029-04-17

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 7

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28 shares

Expires 2029-04-17

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 6

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2029-03-18

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 5

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 250 shares

Expires 2029-03-18

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 4

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188

Underlying: Common Stock · 188 shares

Expires 2028-08-07

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 3

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 188 shares

Expires 2028-08-07

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 2

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75

Underlying: Common Stock · 75 shares

Expires 2028-08-07

F3 · derivative.exercise_price: The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

SEC source: 0001104659-24-097789 · tm2423539-5_4seq1.xml · derivative · entry 1

LAPORTE KATHLEEN · CIK 0001196201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75 shares

Expires 2028-08-07

F1 · kind: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F1 · price: On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 31, 2024 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2 · derivative.exercise_date: This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the "2017 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.